These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11266182)

  • 1. Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5.
    Contour-Galéra MO; Poitout L; Moinet C; Morgan B; Gordon T; Roubert P; Thurieau C
    Bioorg Med Chem Lett; 2001 Mar; 11(5):741-5. PubMed ID: 11266182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the modified Pictet-Spengler cyclization reaction for the preparation of an imidazopyrazine ring: synthesis of new pyrido- and pyrimido-imidazopyrazines.
    Sharma S; Kundu B
    J Comb Chem; 2009; 11(4):720-31. PubMed ID: 19435370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solid phase synthesis of a series of tri-substituted hydantoin ligands for the somatostatin SST5 receptor.
    Sciciński JJ; Barker MD; Murray PJ; Jarvie EM
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3609-14. PubMed ID: 9934480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel non-peptide ligands for the somatostatin sst3 receptor.
    Moinet C; Contour-Galcéra MO; Poitout L; Morgan B; Gordon T; Rouber P; Thurieau C
    Bioorg Med Chem Lett; 2001 Apr; 11(8):991-5. PubMed ID: 11327607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
    Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
    J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting the Nucleophilicity of the Nitrogen Atom of Imidazoles: One-Pot Three-Component Synthesis of Imidazo-Pyrazines.
    Galli U; Hysenlika R; Meneghetti F; Del Grosso E; Pelliccia S; Novellino E; Giustiniano M; Tron GC
    Molecules; 2019 May; 24(10):. PubMed ID: 31117306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palladium-catalyzed direct heck arylation of dual pi-deficient/pi-excessive heteroaromatics. Synthesis of C-5 arylated imidazo[1,5-a]pyrazines.
    Wang JX; McCubbin JA; Jin M; Laufer RS; Mao Y; Crew AP; Mulvihill MJ; Snieckus V
    Org Lett; 2008 Jul; 10(14):2923-6. PubMed ID: 18576663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion.
    Sayer JR; Walldén K; Pesnot T; Campbell F; Gane PJ; Simone M; Koss H; Buelens F; Boyle TP; Selwood DL; Waksman G; Tabor AB
    Bioorg Med Chem; 2014 Nov; 22(22):6459-70. PubMed ID: 25438770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of subtype selective somatostatin receptor agonists.
    Rohrer SP; Schaeffer JM
    J Physiol Paris; 2000; 94(3-4):211-5. PubMed ID: 11087999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spiro[1H-indene-1,4'-piperidine] derivatives as potent and selective non-peptide human somatostatin receptor subtype 2 (sst2) agonists.
    Yang L; Guo L; Pasternak A; Mosley R; Rohrer S; Birzin E; Foor F; Cheng K; Schaeffer J; Patchett AA
    J Med Chem; 1998 Jun; 41(13):2175-9. PubMed ID: 9632348
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and evaluation of imidazo[1,5-a]pyrazines as corticotropin releasing hormone receptor ligands.
    Hartz RA; Gilligan PJ; Nanda KK; Tebben AJ; Fitzgerald LW; Miller K
    Bioorg Med Chem Lett; 2002 Feb; 12(3):291-4. PubMed ID: 11814780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nipecotic and iso-nipecotic amides as potent and selective somatostatin subtype-2 receptor agonists.
    Zhou C; Guo L; Morriello G; Pasternak A; Pan Y; Rohrer SP; Birzin ET; Huskey SE; Jacks T; Schleim KD; Cheng K; Schaeffer JM; Patchett AA; Yang L
    Bioorg Med Chem Lett; 2001 Feb; 11(3):415-7. PubMed ID: 11212124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.
    Rajeswaran WG; Hocart SJ; Murphy WA; Taylor JE; Coy DH
    J Med Chem; 2001 Apr; 44(8):1305-11. PubMed ID: 11312929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor.
    Mulvihill MJ; Cooke A; Rosenfeld-Franklin M; Buck E; Foreman K; Landfair D; O'Connor M; Pirritt C; Sun Y; Yao Y; Arnold LD; Gibson NW; Ji QS
    Future Med Chem; 2009 Sep; 1(6):1153-71. PubMed ID: 21425998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
    Marchand P; Bazin MA; Pagniez F; Rivière G; Bodero L; Marhadour S; Nourrisson MR; Picot C; Ruchaud S; Bach S; Baratte B; Sauvain M; Pareja DC; Vaisberg AJ; Le Pape P
    Eur J Med Chem; 2015 Oct; 103():381-95. PubMed ID: 26383125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis of 2,5-dihydro-1H-pyrroles, 1,3-dioxo-2,3,5,7a-tetrahydro-1H-pyrrolo[1,2-c]imidazoles and 1,4-dioxo-1,2,3,4,6,8a-hexahydropyrrolo[1,2-a]pyrazines using a supported selenium resin.
    Huang X; Xu JF
    J Comb Chem; 2009; 11(3):350-4. PubMed ID: 19220032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A
    Poli D; Falsini M; Varano F; Betti M; Varani K; Vincenzi F; Pugliese AM; Pedata F; Dal Ben D; Thomas A; Palchetti I; Bettazzi F; Catarzi D; Colotta V
    Eur J Med Chem; 2017 Jan; 125():611-628. PubMed ID: 27721147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule somatostatin receptor subtype 4 (sst
    Szőke É; Bálint M; Hetényi C; Markovics A; Elekes K; Pozsgai G; Szűts T; Kéri G; Őrfi L; Sándor Z; Szolcsányi J; Pintér E; Helyes Z
    Neuropharmacology; 2020 Nov; 178():108198. PubMed ID: 32739276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies and sleep-promoting activity of novel 1-chloro-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine derivatives as dual orexin receptor antagonists. Part 2.
    Sifferlen T; Koberstein R; Cottreel E; Boller A; Weller T; Gatfield J; Brisbare-Roch C; Jenck F; Boss C
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3857-63. PubMed ID: 23719231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.